Dr. Tara McMorrow tara.mcmorrow@ucd.ie Tel: 01 716 6819
School of Biomolecular and Biomedical Science Conway Institute PHAR 40060 ARP Lecture 2: Objectives At the end of this lecture, students should have an understanding of the kidney in relation to renal disease
Functional unit of the kidney - Nephron Nephron Tubular Vascular component component Approx. 1 million nephrons in each mammalian kidney
Can lose up to 75% of nephron function and renal function will be maintained by reserve nephrons
difficult to detect damage early Renal Disease Background: Renal disease is a major problem world wide
Increasing incidence 80,000 new cases / year in USA
Major causes include : 1. Diabetes 2. Hypertension 3. Glomerulonephritis
Mechanisms of development are unknown
Thus limited therapies are available General Characteristics
Early Renal Disease: Abnormal urine volume and/or composition Advanced: Edema, electrolyte abnormalities, anemia, etc. Rate of Progression: Disease-dependent Disease Course: Transient-fatal: Disease- dependent Pain: Variable, depending on nature of disease Kidney Sites Susceptible to Renal Disease General: Renal medulla: Low oxygen environment: Ischemia Glomeruli: Structure predisposes it to immune complex deposition and complement fixation Tubules - generally involved in endstage or chronic kidney disease Post-Renal Structures (ureters, bladder) Malformations, Obstruction, Masses (i.e. cancer) Acute Kidney Disease
Prerenal: Decreased cardiac output and urine volume depletion Drug-induced or related Intrarenal: Inflammatory disease Acute tubular necrosis Postrenal: - Obstruction Slow decline in kidney function - eventually progresses to End Stage Renal Disease (ESRD)
Generally develops as a result of another condition - Diabetes (28%) - Hypertension (25%) - Glomerulonephritis (21%) - Polycystic Kidney Disease (4%) - Other (23%): Obstruction, infection, drugs.
Chronic Kidney Disease
Renal diseases are varied and can result from a toxic insult or may be immune mediated They may be classified by their location of onset - Glomerular disease- glomerulonephritis Tubulointerstitial disease- tubulointerstitial nephritis Most of the conditions result in a fibrotic or sclerotic phenotype characterised by excess extracellular matrix deposition Regardless of the initial insult, development of renal fibrosis leads to end-stage renal disease and ultimately kidney failure Renal Disease Classification Renal ultra-structure of normal and fibrotic tissue (a) Normal kidney architecture displaying a normal glomerulus ( ), bowmans space ( ), mesangial cells ( ), basement membrane ( ) supporting the tubular epithelial cells ( ) separated by the interstitial space ( ).
(b) In the glomerular nephritis section there is an enlarged glomerulus, reduced bowmans space, proliferating mesangial cells, an expansive interstitium and disruption of tubular function.
(a) (b) Kidney Histology Glomerular Diseases
Glomerulonephritis (GN) is one of the most important causes of renal disease world-wide.
Examples of GN include: 1. Membranous nephritis 2. Post-infectious glomerulonephritis 3. Lupus glomerulonephritis 4. IgA Nephropathy 5. Goodpastures Syndrome 6. Diabetic Nephropathy 7. Glomerulosclerosis Glomerulonephritis Glomerulonephritis is the third most common cause of end-stage renal disease after diabetes and hypertension Accounts for 10-15% of ESRD patients Immunological events lead to - complement activation - fibrin deposition - platelet aggregation - inflammation
Acute Glomerulonephritis Chronic Glomerulonephritis Glomerulonephritis: scarring of the cortex Tubular Diseases The main tubular disease is tubulointerstitial nephritis Acute tubulointerstitial nephritis- due to hypersensitivity reactions to drugs Chronic tubulointerstitial nephritis- due to drugs, diabetes, chemicals
Acute Tubulointerstitial Nephritis Chronic Tubulointerstitial Nephritis Tubulointerstitial Nephritis Progressive Renal Disease Common histological end point:
Pathological process resulting from insult / injury leading to tissue dysfunction and organ failure Fibrosis - The Final Common Pathway for renal diseases that progress to ESRF
Level of fibrosis correlates closely with the degree of renal dysfunction
Glomerulosclerosis Glomerulosclerosis is a key endpoint in progressive renal disease
Leads to scarring of the glomeruli which cannot be repaired
Eventually leads to end stage renal disease
Tubulointerstitial fibrosis Tubulointerstitial fibrosis is a hallmark of progressive renal disease
Progression of chronic renal insufficiency is closely linked to the severity of tubulointerstitial changes
Level of proximal tubular damage also correlates closely with the degree of renal dysfunction FIBROSIS :
1. Increased deposition of fibronectin, collagens 2. Increased fibroblast proliferation 3. Increase in mononuclear cells 4. Accumulation of matrix proteins : - inadequate matrix degradation
The End-Stage Kidney Kidney fibrosis (ESRD)
Tubulointerstitial Fibrosis is the final common pathway leading to ESRF - correlates most closely with declining renal function
Caused by accumulation of excess extracellular matrix (ECM) in the renal tubular interstitium ESRD Patients with chronic renal impairment tend to progress to ESRD No treatment options except renal replacement therapy i.e. dialysis Transplantation-long waiting lists and strict criteria Kidney Disease Summary Prevalence of kidney disease - 1 in 9 adults develop chronic kidney disease
Renal fibrosis is a common final pathway for numerous kidney dysfunctions - e.g. Tubulointerstitial fibrosis, diabetic nephropathy
Renal fibrosis is characterised by: - loss of renal function - decreased number of epithelial cells - excess ECM accumulation - infiltration of fibroblasts 5 Stages of Kidney Disease Many People With Kidney Disease Still in the Dark- March 2005 Report Almost 45 percent of people with stage 4 kidney disease only one stage behind kidney failure had never been told there was anything wrong with their kidneys.
More than 20 million Americansone in nine adultshave chronic kidney disease. More than 20 million more are at increased risk for developing kidney disease, and most don't even know it.
Relevant References Detection and Evaluation of Chronic Kidney Disease. Snyder S and Pendergraph B. 2005 AFP 72(9): 1723-1732
Management of Acute Renal Failure. Needham E. 2005 AFP 72(9): 1739-1746 www.aafp.org/afp